Rajwant Sodhi - 04 Jan 2022 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
s/ David B. Berger, Attorney-in-Fact for Rajwant S. Sodhi
Issuer symbol
TNDM
Transactions as of
04 Jan 2022
Net transactions value
$0
Form type
4
Filing time
05 Jan 2022, 18:17:56 UTC
Previous filing
14 Oct 2021
Next filing
19 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +1,069 $0.000000 1,069 04 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 +1,069 +100% $0.000000 2,139 04 Jan 2022 Common Stock 1,069 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F2 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company.
F3 This RSU award was granted on January 4, 2021. 33% of the RSU vested on January 4, 2022 and the remaining 67% will vest annually over the next two years.
F4 The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.